Green Thumb Industries (OTCMKTS:GTBIF) and NeurAxis (NASDAQ:NRXS) Head to Head Survey

NeurAxis (NASDAQ:NRXS) and Green Thumb Industries (OTCMKTS:GTBIF) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Valuation and Earnings

This table compares NeurAxis and Green Thumb Industries”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$5.32 million	17.95	-$14.63 million	($0.78)	-9.74
Green Thumb Industries	$1.18 billion	1.09	$114.15 million	$0.54	12.11

Green Thumb Industries has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares NeurAxis and Green Thumb Industries’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
Green Thumb Industries	10.48%	6.03%	4.09%

Volatility and Risk

NeurAxis has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Green Thumb Industries has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for NeurAxis and Green Thumb Industries, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0	1	1	0	2.50
Green Thumb Industries	0	1	1	0	2.50

NeurAxis presently has a consensus price target of $13.00, indicating a potential upside of 71.05%. Green Thumb Industries has a consensus price target of $18.00, indicating a potential upside of 175.23%. Given Green Thumb Industries’ higher probable upside, analysts clearly believe Green Thumb Industries is more favorable than NeurAxis.

Institutional and Insider Ownership

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 0.1% of Green Thumb Industries shares are held by institutional investors. 21.1% of NeurAxis shares are held by insiders. Comparatively, 9.4% of Green Thumb Industries shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Green Thumb Industries beats NeurAxis on 8 of the 12 factors compared between the two stocks.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

About Green Thumb Industries

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.